ATI-450: A Novel MK2 Pathway Inhibitor - Preclinical & Clinical Translational Studies to Predict Human Dose

ASPET 2023 Annual Meeting Abstract - Pharmacogenomics and Translational Pharmacology Pub Date : 2023-05-18 DOI:10.1124/jpet.122.541040

H. Hope, S. Hockerman, Matthew J. Saabye, L. Stillwell, Rakesh H. Basavalingappa, Catherine Emanual, S. Mnich, Madison C. Bangs, Emma E. Huff, Aparna Kaul, A. Hildebrand, M. Cardillo, A. Aggarwal, Joseph B. Monahan

引用次数: 0

Abstract

查看原文本刊更多论文

ATI-450:一种新型MK2通路抑制剂-临床前和临床转化研究预测人体剂量

，

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ASPET 2023 Annual Meeting Abstract - Pharmacogenomics and Translational Pharmacology

自引率

0.00%

发文量